Medical Journals

The E7 Proteins of Low- and High-risk Human Papillomaviruses Share the Ability to Target the Prb Family Member P130 for Degradation.

Authors:
  • Zhang Benyue
  • Chen Wei
  • Roman Ann

From: Department of Microbiology and Immunology and The Walther Oncology Center, Indiana University School of Medicine and The Walther Cancer Institute, Indianapolis, IN 46202, USA.

Proceedings of the National Academy of Sciences of the United States of America

  • Publish Date: Jan 2006
  • ISSN: 0027-8424
  • Volume: 103
  • Issue: 2
  • Pages: 437-42
  • Medium: Print
  • Language: English
  • Citation (JAMA): Zhang Benyue, Chen Wei, Roman Ann, et al. The E7 Proteins of Low- and High-risk Human Papillomaviruses Share the Ability to Target the Prb Family Member P130 for Degradation.. Proc. Natl. Acad. Sci. U.S.A. Jan 2006;103:437-42

Abstract

High-risk human papillomaviruses (HPVs) (e.g., HPV-16) cause anogenital and head and neck cancers, and low-risk HPVs (e.g., HPV-6) cause benign hyperproliferative disease. The E7 protein of HPV-16 binds all retinoblastoma tumor suppressor protein (pRB) family members with higher affinity than HPV-6E7. The HPV-16 E7 protein has been reported to target pRB family members for degradation and to immortalize cells. Here we tested the hypothesis that the low-risk E7 protein has an intrinsic ability to decrease expression of pRB family members. First, we introduced a high-affinity pRB-binding site into HPV-6 E7 (6E7G22D) and showed that, in human foreskin keratinocytes, HPV-6 E7G22D decreased the level of pRB protein but not pRB mRNA. Second, we analyzed the ability of wild-type HPV-6 E7 to destabilize the other pRB family members, p107 and p130. HPV-6 E7, like HPV-16 E7, decreased the level of p130 protein. This decrease was inhibited by MG132, a proteasome inhibitor. Binding of HPV-6 E7 to p130 was necessary but not sufficient to decrease the level of p130. Furthermore, the destabilization of p130 correlated with a decrease in the expression of involucrin, a differentiation marker. We suggest that the shared activity of HPV-16 E7 and HPV-6 E7 to destabilize p130 and decrease or delay differentiation may be related to the role of E7 in the HPV life cycle. The added ability of HPV-16 E7 to regulate pRB and p107 may be related to oncogenic activity.

Mesh Headings (Keywords): Amino Acid Sequence, Binding Sites, Cell Differentiation, Cells, Cultured, Culture Media, Humans, Keratinocytes, Molecular Sequence Data, Oncogene Proteins, Viral, Papillomaviridae, Proteasome Endopeptidase Complex, Retinoblastoma-Like Protein p130, Risk Factors


Check for Full Text / PubMed Unique Identifier (PMID): 16381817


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.